首页> 外文期刊>Iranian polymer journal >Self-assembly and drug release control of dual-responsive copolymers based on oligo(ethylene glycol)methyl ether methacrylate and spiropyran
【24h】

Self-assembly and drug release control of dual-responsive copolymers based on oligo(ethylene glycol)methyl ether methacrylate and spiropyran

机译:基于低聚(乙二醇)甲基醚甲基丙烯酸酯和螺吡喃的双响应共聚物的自组装和药物释放控制

获取原文
获取原文并翻译 | 示例

摘要

To compare the synthesis and drug release of random and block copolymers, random and block copolymerizations of oligo(ethylene glycol)methyl ether methacrylate (OEGMA) and 1-(2-methacryloxyethyl)-3,3-dimethyl-6-nitrospiro-(2H-1-benzopyran-2,2-indoline) (SPMA) were carried out by atom transfer radical polymerization. The H-1 NMR and GPC results indicated the targeted random and block copolymers were successfully synthesized. Critical micelle concentrations of random and block copolymers were determined as 0.0178mg/mL and 0.0265mg/mL, and the micelle aggregation numbers of the random and block copolymers were calculated as approximately 17 and 13, respectively, indicating that more molecular chains were required to form a stable polymeric micelle for a random than its block copolymer. A lower critical solution temperature of 37 degrees C, the human body temperature, was obtained for two copolymer samples, suggesting that they might have potential application in the biomedical field. During the self-assembly, the morphology of block copolymer micelles was more regular than that of random copolymer, and both copolymers exhibited the exchange of hydrophilic and hydrophobic segments called as Schizophrenic behavior under UV light irradiation at 50 degrees C. With doxorubicin as a model molecule in drug release control, heating and ultraviolet light irradiation could accelerate the drug release process to some extent, indicating the potential application of the resulting random and block copolymers in drug release and bioengineering.
机译:为了比较无规和嵌段共聚物的合成和药物释放,低聚(乙二醇)甲基丙烯酸甲酯(OEGMA)和1-(2-甲基丙烯酰氧基乙基)-3,3-二甲基-6-硝基螺-(2H)的无规和嵌段共聚通过原子转移自由基聚合进行-1-苯并吡喃-2,2-二氢吲哚(SPMA)。 H-1 NMR和GPC结果表明已成功合成了目标无规和嵌段共聚物。确定无规和嵌段共聚物的临界胶束浓度为0.0178mg / mL和0.0265mg / mL,无规和嵌段共聚物的胶束聚集数分别约为17和13,表明需要更多的分子链才能形成稳定的聚合物微团,其嵌段共聚物比无规。两个共聚物样品的临界溶液温度较低,为人体温度37摄氏度,这表明它们在生物医学领域可能具有潜在的应用。在自组装过程中,嵌段共聚物胶束的形态比无规共聚物的形态更规则,并且两种共聚物均表现出亲水性和疏水性部分的交换,这在50°C的紫外线照射下称为精神分裂症行为。以阿霉素为模型分子在药物释放控制,加热和紫外线照射中可以在一定程度上加速药物释放过程,表明所得无规和嵌段共聚物在药物释放和生物工程中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号